HCMT
ABMD

Highland Capital Management (Tennessee)’s Abiomed Inc ABMD Stock Holding History

Highland Capital Management (Tennessee)’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-6,840
Closed -$2.18M – 358
2021
Q1 		$2.18M Sell
6,840
-626
-8% -$200K 0.13% 172
2020
Q4 		$2.42M Buy
+7,466
New +$2.07M 0.16% 160

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Highland Capital Management (Tennessee)'s ABMD Position: Q2 2021 in Review

Highland Capital Management (Tennessee) sold out of Abiomed Inc (ABMD) in Q2 2021, closing a stake of 6,840 shares — an estimated $2.18M sold.

Highland Capital Management (Tennessee) first reported a position in ABMD in Q4 2020 and held it in 2 quarters. The position peaked at $2.42M in Q4 2020. 474 funds tracked by Wall St. Rank hold ABMD as of Q2 2021.

  • Highland Capital Management (Tennessee) reported no remaining Abiomed Inc position as of Q2 2021 after selling out during the quarter.
  • Highland Capital Management (Tennessee) sold 6,840 Abiomed Inc shares in Q2 2021, an estimated $2.18M.
  • Highland Capital Management (Tennessee) first reported a position in Abiomed Inc in Q4 2020 and held it in 2 quarters.
  • Highland Capital Management (Tennessee)'s Abiomed Inc position peaked at $2.42M in Q4 2020.
  • 474 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2021.

Based on Highland Capital Management (Tennessee)'s 13F filing for Q2 2021, filed 30 Jul 2021.